Company Peptron, Inc.

Equities

A087010

KR7087010005

Biotechnology & Medical Research

Business description: Peptron, Inc.

Managers: Peptron, Inc.

Members of the board: Peptron, Inc.

Shareholders: Peptron, Inc.

Company details: Peptron, Inc.

Bio Therapeutic Drugs

Sector

Income Statement and Estimates

End-of-day quote Korea S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
52,500.00 ^KRW	+11.70%		+15.64%	+30.43%

2023	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT
2023	Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI

Peptron, Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services. The Company manufactures raw material medicines and some functional cosmetics. The Company distributes its products within domestic market and to overseas markets.

Director	Title	Age	Since
Min-Ho Song CEO	Chief Executive Officer	63	21-03-29
Ho-Il Choi CEO	Chief Executive Officer	58	97-11-20
Seung-Gu Jang DFI	Director of Finance/CFO	58	99-06-30
Gi-Young Lee AUD	Comptroller/Controller/Auditor	59	17-03-26

See PEPTRON, INC. governance

Manager	Title	Age	Since
Ho-Il Choi CEO	Chief Executive Officer	58	97-11-20
Seung-Gu Jang DFI	Director of Finance/CFO	58	99-06-30
Young-Go Jung BRD	Director/Board Member	49	14-03-30
Hyo-Seop Kim BRD	Director/Board Member	53	15-06-30
Sang-Heon Lee BRD	Director/Board Member	57	-
Min-Ho Song CEO	Chief Executive Officer	63	21-03-29

Composition of the Board of Directors

Name	Equities	%	Valuation
Ho-Il Choi 8.366 %	1,728,200	8.366 %	64 M ₩
Peptron, Inc. Employee Stock Option Associate 0.9466 %	195,534	0.9466 %	7 M ₩
Seung-Gu Jang 0.8327 %	172,010	0.8327 %	6 M ₩
POLARIS UNO, INC. 0.6431 %	132,853	0.6431 %	5 M ₩
Mi-yong Kang 0.1583 %	32,700	0.1583 %	1 M ₩

List of PEPTRON, INC. shareholders

Peptron, Inc.

37-24 Yuseong-daero 1628beon-gil Yuseong-gu

34054, Daejeon

http://www.peptron.co.kr

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
PEPTRON, INC.	+11.70%	+15.64%	+20.55%	+323.39%	723M
REGENERON PHARMACEUTICALS, INC.	+0.45%	-3.22%	+36.94%	+75.48%	123B
VERTEX PHARMACEUTICALS INCORPORATED	+0.84%	-0.80%	+36.73%	+151.76%	122B
ARGENX SE	+0.74%	+4.75%	+0.02%	+76.27%	32.18B
BIONTECH SE	-1.35%	+11.51%	-15.84%	-71.57%	23.93B
BEIGENE, LTD.	+6.80%	+11.93%	+0.91%	-40.01%	21B
GENMAB A/S	-2.37%	-3.08%	-30.21%	-35.00%	17.38B
WUXI APPTEC CO., LTD.	+3.35%	-2.18%	-50.27%	-72.63%	14.82B
VAXCYTE, INC.	-2.31%	+4.03%	+116.62%	+334.06%	14.38B
SUMMIT THERAPEUTICS INC.	-1.18%	+89.17%	+1,292.64%	+249.23%	16.64B
Average	+1.56%	+12.08%	+140.81%	+99.10%	38.52B
Weighted average by Cap.	+0.33%	+3.98%	+79.35%	+91.11%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

More financial data